• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Zevra Therapeutics, Inc. - Common Stock (NQ: ZVRA )

    4.490 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 4.490
    Bid (Size) 4.400 (2)
    Ask (Size) 4.970 (10)
    Prev. Close 4.490
    Today's Range 4.490 - 4.490
    52wk Range 3.890 - 7.280
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ZVRA Stock Earnings: Zevra Therapeutics Beats EPS, Misses Revenue for Q1 2024
    ZVRA stock results show that Zevra Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Zevra Therapeutics, Inc. (NASDAQ: ZVRA) Letter to Stakeholders Looks Like Launch Code to Drive Value
    Via Investor Brand Network

    Performance

    YTD
    -34.26%
    -34.26%
    1 Month
    -1.97%
    -1.97%
    3 Month
    -33.97%
    -33.97%
    6 Month
    -6.07%
    -6.07%
    1 Year
    -23.12%
    -23.12%

    More News

    Read More
    ZEVRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Zevra Therapeutics, Inc. on Behalf of Zevra Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zevra Therapeutics, Inc. (ZVRA)
    From Kirby McInerney LLP
    Via GlobeNewswire
    Zevra Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Earnings Outlook For Zevra Therapeutics
    Via Benzinga
    ZVRA Stock Earnings: Zevra Therapeutics Misses EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Earnings Scheduled For March 28, 2024
    Via Benzinga
    Zevra Therapeutics's Earnings: A Preview
    Via Benzinga
    Zevra Therapeutics's Earnings: A Preview
    Via Benzinga
    A Preview Of Zevra Therapeutics's Earnings
    Via Benzinga
    Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    BioMedNewsBreaks – Zevra Therapeutics Inc. (NASDAQ: ZVRA) Resubmits Arimoclomol New Drug Application to the FDA
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks — Zevra Therapeutics Inc. (NASDAQ: ZVRA) Names New President, CEO and Director
    Via Investor Brand Network
    Topics Retirement
    Exposures Pension
    Earnings Scheduled For November 7, 2023
    Via Benzinga
    Health Care Company Zevra Therapeutics Announces Merger With Acer Therapeutics
    Via Benzinga
    Why Is Acer Therapeutics Stock Trading Higher Today?
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq -
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Why Is Acer Therapeutics (ACER) Stock Up 85% Today?
    Via InvestorPlace
    Earnings Scheduled For August 14, 2023
    Via Benzinga
    Earnings Scheduled For May 15, 2023
    Via Benzinga
    Citius Pharmaceuticals Approaches End Of Trial For Catheter-Related Bloodstream Infections – How Are Analysts Scoring Its Stock?
    Via Benzinga
    Over $7M Bet On This Consumer Defensive Stock? Check Out These 4 Penny Stocks Insiders Are Buying
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
    Via Benzinga
    Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.